11C-or 18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer

Paola Mapelli; Elena Incerti; Francesco Ceci; Paolo Castellucci; Stefano Fanti; Maria Picchio

doi:10.2967/jnumed.115.169755

¹¹C-or ¹⁸F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer

Paola Mapelli, Elena Incerti, Francesco Ceci, Paolo Castellucci, Stefano Fanti, Maria Picchio

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both. Differentiation between the two patterns of relapse is critical for choosing the proper treatment strategy. Choline PET/CT could be of help in discriminating patients with local, lymph node, and bone recurrences, thus having an impact on patient management.

Original language	English
Pages (from-to)	43S-48S
Journal	Journal of Nuclear Medicine
Volume	57
DOIs	https://doi.org/10.2967/jnumed.115.169755
Publication status	Published - Oct 1 2016

Keywords

C-choline
F-choline
Biochemical recurrence
PET/CT
Prostate cancer

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2967/jnumed.115.169755

Fingerprint Dive into the research topics of '<sup>11</sup>C-or <sup>18</sup>F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer'. Together they form a unique fingerprint.

Cite this

@article{6d6dae519ee743aa85916f0a859c8ea3,

title = "11C-or 18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer",

abstract = "Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both. Differentiation between the two patterns of relapse is critical for choosing the proper treatment strategy. Choline PET/CT could be of help in discriminating patients with local, lymph node, and bone recurrences, thus having an impact on patient management.",

keywords = "C-choline, F-choline, Biochemical recurrence, PET/CT, Prostate cancer",

author = "Paola Mapelli and Elena Incerti and Francesco Ceci and Paolo Castellucci and Stefano Fanti and Maria Picchio",

year = "2016",

month = oct,

day = "1",

doi = "10.2967/jnumed.115.169755",

language = "English",

volume = "57",

pages = "43S--48S",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

}

TY - JOUR

T1 - 11C-or 18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer

AU - Mapelli, Paola

AU - Incerti, Elena

AU - Ceci, Francesco

AU - Castellucci, Paolo

AU - Fanti, Stefano

AU - Picchio, Maria

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both. Differentiation between the two patterns of relapse is critical for choosing the proper treatment strategy. Choline PET/CT could be of help in discriminating patients with local, lymph node, and bone recurrences, thus having an impact on patient management.

AB - Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both. Differentiation between the two patterns of relapse is critical for choosing the proper treatment strategy. Choline PET/CT could be of help in discriminating patients with local, lymph node, and bone recurrences, thus having an impact on patient management.

KW - C-choline

KW - F-choline

KW - Biochemical recurrence

KW - PET/CT

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84991312292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991312292&partnerID=8YFLogxK

U2 - 10.2967/jnumed.115.169755

DO - 10.2967/jnumed.115.169755

M3 - Article

AN - SCOPUS:84991312292

VL - 57

SP - 43S-48S

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

ER -